Beckman Coulter, Inc. Announces Conference Call to Discuss First Quarter 2003 Results on Friday, April 25, 2003.Business Editors FULLERTON, Calif.--(BUSINESS WIRE)--April 9, 2003 Beckman Coulter, Inc. (NYSE NYSE See: New York Stock Exchange : BEC) announced today it will host a conference call to discuss the company's first quarter 2003 results on Friday, April 25, 2003 at 9:30 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT . Earnings will be released earlier that morning. The call will be hosted by John P. Wareham, chairman, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , and Amin Khalifa, vice president finance and CFO See Chief Financial Officer. . The call may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation 9697543. There will also be a live webcast of the call. It will be accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com or at www.streetevents.com . When accessing the webcast through the Beckman Coulter site, select "go to IR" under Investor Relations Investor relations The process by which the corporation communicates with its investors. and find the call listed under "What's New". The webcast will be archived on both websites for future on-demand replay through Friday, May 9, 2003. Beckman Coulter, Inc. is a leading manufacturer of instrument systems, chemistries and supplies that simplify and automate laboratory processes. At the forefront of medical discovery, in clinical research and through the often life-saving process of clinical diagnostics, Beckman Coulter's 200,000 installed systems provide essential biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. intelligence to enhance health care around the world. The company, based in Fullerton, Calif., reported 2002 annual sales of $2.06 billion with 62 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, access the Beckman Coulter World Wide Web Information Service at www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion